CoChat

Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis

Open access
Beyer, Christian, Reichert, Helena, Akan, Hümeyra, Mallano, Tatjana, Schramm, Amelie, Dees, Clara, Palumbo-Zerr, Katrin, Lin, Neng Yu, Distler, Alfiya, Gelse, Kolja, Varga, John, Distler, Oliver, Schett, Georg, Distler, Jörg H W · 2013 · Annals of the Rheumatic Diseases
Cited by 114

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND OBJECTIVES: Fibrosis is a major socioeconomic burden, but effective antifibrotic therapies are not available in the clinical routine. There is growing evidence for a central role of Wnt signalling in fibrotic diseases such as systemic sclerosis, and we therefore evaluated the translational potential of pharmacological Wnt inhibition in experimental dermal fibrosis. METHODS: We examined the antifibrotic effects of PKF118-310 and ICG-001, two novel inhibitors of downstream canonical Wnt signalling, in the models of prevention and treatment of bleomycin-induced dermal fibrosis as well as in experimental dermal fibrosis induced by adenoviral overexpression of a constitutively active transforming growth factor (TGF)-β receptor I. RESULTS: PKF118-310 and ICG-001 were well tolerated throughout all experiments. Both therapeutic approaches showed antifibrotic effects in preventing and reversing bleomycin-induced dermal fibrosis as measured by skin thickness, hydroxyproline content and myofibroblast counts. PKF118-310 and ICG-001 were effective in inhibiting TGF-β receptor I-driven fibrosis as assessed by the same outcome measures. CONCLUSIONS: Blockade of canonical Wnt signalling by PKF118-310 and ICG-001 showed antifibrotic effects in different models of skin fibrosis. Both therapies were well tolerated. Although further experimental evidence for efficacy and tolerability is necessary, inhibition of canonical Wnt signalling is a promising treatment approach for fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2012-202544

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 114

Metadata

Authors
Beyer, C., Reichert, H., Akan, H., Mallano, T., Schramm, A., Dees, C., Palumbo-Zerr, K., Lin, N. Y., Distler, A., Gelse, K., Varga, J., Distler, O., Schett, G., & Distler, J. H. W.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2013-07
Volume
72
Issue
7
Pages
1255-1258
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2133996143
Cited by
114
References
7
FWCI
9.78
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. https://app.cochat.ai/papers/10.1136/annrheumdis-2012-202544
The paper
Beyer, C., Reichert, H., Akan, H., Mallano, T., Schramm, A., Dees, C., Palumbo-Zerr, K., Lin, N. Y., Distler, A., Gelse, K., Varga, J., Distler, O., Schett, G., & Distler, J. H. W. (2013). Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-202544

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.